Celgene's most recent trend suggests a bullish bias. One trading opportunity on Celgene is a Bull Put Spread using a strike $113.00 short put and a strike $108.00 long put offers a potential 28.21% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $113.00 by expiration. The full premium credit of $1.10 would be kept by the premium seller. The risk of $3.90 would be incurred if the stock dropped below the $108.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Celgene is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Celgene is bullish.
The RSI indicator is at 67.76 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Celgene
7 Biotech stocks to buy now
Tue, 02 Dec 2014 22:00:00 GMT
4 Stocks, 4 trades: F, BIIB, PCLN & RCL
Tue, 02 Dec 2014 17:27:00 GMT
Cramer's Mad Dash: Love CY & BIIB
Tue, 02 Dec 2014 14:23:00 GMT
Meet 5 Top Drug Stocks That Are Bolting Past Market
Tue, 02 Dec 2014 13:02:00 GMT
Celgene Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Corporation
Mon, 01 Dec 2014 21:31:18 GMT
noodls – SUMMIT, N.J.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ:CELG) received notice of an unsolicited “mini-tender” offer by TRC Capital Corporation to purchase up to 1,000,000 shares of Celgene's …
Related Posts
Also on Market Tamer…
Follow Us on Facebook